Amisulpride
Therapeutic Category
- Anti-emetic, Anti-psychotic
Innovator Brand
GMP
DMF
Filed
Under Filing
Sample
Indication
Amisulpride API with Cas # 71675-85-9, is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
CTX Lifesciences, is one of the leading Active Pharmaceutical Ingredients (API) manufacturers and suppliers globally for Amisulpride API with Cas # 71675-85-9. We are a leading exporter of Amisulpride API with Cas # 71675-85-9. We are a trusted supplier with API exports in more than 87 Countries including the US, Europe, Brazil, Latin America, China, Korea,Iran, Middle East and other emerging markets.
CTX Lifesciences is one of the leading manufacturer & supplier of Amisulpride API with Cas # 71675-85-9. This product is provided from our GMP compliant plant with product made under complete cGMP conditions. We provided with documentation support Drug Master File(DMF). Our manufacturing plant at Surat has accreditation by US-FDA, EDQM , EMA , ANVISA, KFDA, MOH IRAN, Health Canada & Russian Authorities.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.